Update of the non-chemotherapy drug-induced agranulocytosis [4];Agranulocytoses médicamenteuses: Données actuelles

Annales de Biologie Clinique

Volumn 61, Issue 1, 2003, Pages 121-124

  Andres E ^a   Maloisel, F ^a   Kaltenbach, G ^a   Noel, E ^a   Alt, M ^a   Martin Hunyadi, C ^a   Henoun Loukili, N ^a   Weber, J C ^a   Kurtz, J E ^a   Sibilia, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

AGRANULOCYTOSIS; BLOOD; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; DRUG THERAPY; HUMAN; LETTER; LEUKOCYTE COUNT;

AGRANULOCYTOSIS; DRUG THERAPY; HUMANS; LEUKOCYTE COUNT; PHARMACEUTICAL PREPARATIONS;

EID: 0037274575     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)

1. JobertE, Latger-Cannard V, Lesesve JF, et al. L'agranulocytose médicamenteuse: place du myélogramme et des tests biologiques. Ann Biol Clin 2001; 59: 329-33.
2. Andrès E, Kurtz JE, Maloisel F. Non-chemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature. Clin Lab Haematol 2002; 24: 99-106.
3. Andrès E, Maloisel F, Offner C, et al. Agranulocytoses médicamenteuses: expérience du CHRU de Strasbourg. Sem Hop Paris 1998; 74: 1005-10.
4. Dreyfus F. Agranulocytose médicamenteuse. In: Dreyfus B, ed. L'Hématologie. Paris: Flammarion 1992: 568-71.
5. Bénichou C, Solal-Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol 1993; 33: 257-62.
6. Fattinger K, Roos M, Vergeres P, et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss Departments of Internal Medicine. Brit J Clin Pharmacol 2000; 49: 158-67.
7. van der Klauw MM, Goudsmit R, Halie MR, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 1999; 159: 369-74.
8. Andrès E, Maloisel F, Kurtz JE, et al. Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. Eur J Intern Med 2002; 13: 324-8.
9. Andrès E, Kurtz JE, Martin-Hunyadi C, et al. Non-chemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor. Am J Med 2002; 112: 460-4.
10. Maloisel F, Andrès E, Kaltenbach G, et al. Prognostic factors of hematological recovery in nonchemotherapy drug-induced agranulocytosis: a study of 91 patients from a single institution. Haematologica 2002: soumis.
11. Andrès E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel F. The use of haematopoietic growth factors in antithyroid-related drug-induced agranulocytosis: a report of 20 patients. QJM 2001; 94: 423-8.
12. Andrès E, Noel E, Maloisel F. Nonchemotherapy drug-induced agranulocytosis: interest of hematopoietic growth factors. J Intern Med 2002; 251: 533-4.
13. Andrès E, Maloisel F, Kurtz JE, et al. Les facteurs de croissance hématopoïétique ont-ils une place dans le traitement des agranulocytoses médicamenteuses? Rev Med Interne 2000; 21: 580-5.
14. Sprikkelman A, de Wolf JTM, Vellenga E. Application of haematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia 1994; 8: 2031-6.
15. Beauchesne MF, Shalansky SJ. Nonchemotherapy drug-induced agranulocytosis: a review of 118 patients treated with colony-stimulating factors. Pharmacotherapy 1999; 19: 299-305.